Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant). [electronic resource]
Producer: 20200218Description: e18904 p. digitalISSN:- 1536-5964
- Humans
- Amyotrophic Lateral Sclerosis -- drug therapy
- Australia
- Dimethyl Fumarate -- administration & dosage
- Disease Progression
- Double-Blind Method
- Neuroprotective Agents -- administration & dosage
- New Zealand
- Quality of Life
- Randomized Controlled Trials as Topic
- Research Design
- Clinical Trials, Phase II as Topic
- Multicenter Studies as Topic
No physical items for this record
Publication Type: Clinical Trial Protocol; Journal Article
There are no comments on this title.
Log in to your account to post a comment.